Senior Director, Global Diagnostics

AstraZeneca•Gaithersburg, MD

3d•$231,988 - $347,983•Hybrid

About The Position

AstraZeneca is seeking a Senior Director, Global Diagnostics for ETCAMAH to join its Global Diagnostics commercial team. The role leads commercial activities for diagnostics across key indications and launch brands, particularly ETCAMAH and other breast indications, and provides biomarker and diagnostics expertise to help shape the breast tumor strategy. The position works across functions and geographies to align diagnostics capabilities with commercial and patient needs. The role supports development and execution of the integrated global diagnostics strategy for breast indications and leads diagnostic commercialization and marketing planning, with a focus on launch readiness, growth, and patient impact. It partners with commercial, medical affairs, R&D, insights and analytics, market access, local affiliates, and external oncology stakeholders. The position also helps address biomarker testing adoption, patient journeys, and diagnostic sample testing pathways; enables markets to improve awareness, adoption, access, availability, and accuracy of biomarker testing; and uses insights and performance monitoring to refine strategy and execution. Based at AstraZeneca’s Gaithersburg, Maryland campus, the position follows a hybrid in-person arrangement with an expectation of working from the office an average of at least three days per week. The annual base pay range is $231,988 to $347,983. The role is eligible for short-term incentive bonuses and equity-based awards. Benefits include qualified retirement programs, paid time off, and health, dental, and vision coverage, subject to applicable plan terms.

Requirements

Bachelor’s degree in business, life sciences, or a related field.
10 years of experience in pharmaceutical and/or diagnostics marketing.
Demonstrated track record in diagnostics launch and commercialization, particularly in oncology.
Team-oriented leadership, excellent written and verbal communication skills, and the ability to influence across all levels in a matrix environment.
Global or in-market experience developing and executing commercial strategies for diagnostics.
Strong analytical skills and the ability to translate analysis into actionable strategy.
Thorough understanding of drug development and commercialization processes and the evolving breast biomarker landscape.
Problem-solving skills and ability to thrive in a dynamic, rapidly changing environment.

Nice To Haves

Advanced degree (MD, PhD, PharmD, or MBA) in a relevant discipline.
Global marketing experience, including diagnostic and therapeutic launches.
In-market launch experience.
Solid technical background in diagnostics development and biomarker science.

Responsibilities

Support development and execution of the integrated global diagnostics strategy for breast indications, aligned with franchise brand plans and commercial objectives.
Drive the creation and implementation of commercialization and marketing plans for each diagnostic, focusing on launch readiness, growth, and patient impact.
Coordinate diagnostic initiatives globally with franchise commercial teams, medical affairs, R&D, insights and analytics, market access, and local market affiliates.
Build and nurture partnerships with external oncology stakeholders, including patient advocacy and policy groups, diagnostic developers, key opinion leaders, and HTA/payer organizations.
Provide strategic and operational leadership to address biomarker testing adoption, patient journeys, and diagnostic sample testing pathways.
Enable markets to develop and execute strategies that improve awareness, adoption, access, availability, and accuracy of biomarker testing.
Gather and use internal and external insights to inform strategy, monitor performance, and adjust tactics.
Lead cross-functional initiatives and promote effective communication, collaboration, and execution across functions and geographies.
Represent diagnostics strategy and progress in key business meetings and deliver critical presentations and updates to leadership on time.